Wealth Alliance Sells 108 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wealth Alliance decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,556 shares of the healthcare conglomerate’s stock after selling 108 shares during the quarter. Wealth Alliance’s holdings in UnitedHealth Group were worth $2,925,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Kraft Davis & Associates LLC grew its holdings in shares of UnitedHealth Group by 3.4% during the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after purchasing an additional 19 shares in the last quarter. Secure Asset Management LLC grew its holdings in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after purchasing an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after purchasing an additional 19 shares in the last quarter. Bensler LLC boosted its stake in UnitedHealth Group by 0.3% in the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after buying an additional 19 shares in the last quarter. Finally, Texas Capital Bancshares Inc TX boosted its stake in UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after buying an additional 19 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Analysts Set New Price Targets

UNH has been the topic of several research analyst reports. Piper Sandler reduced their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target on the stock in a research note on Thursday, April 4th. Stephens reissued an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Three investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $573.80.

UnitedHealth Group Trading Up 5.2 %

UNH stock traded up $23.26 during mid-day trading on Tuesday, reaching $468.89. The company’s stock had a trading volume of 9,241,792 shares, compared to its average volume of 4,370,427. The company has a market cap of $432.28 billion, a price-to-earnings ratio of 19.66, a price-to-earnings-growth ratio of 1.20 and a beta of 0.54. The business’s 50 day moving average price is $491.15 and its 200 day moving average price is $515.88. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.54 by $0.37. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.26 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.7 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s payout ratio is 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.